NASDAQ:IBRX | Cash Flow Statement | ImmunityBio, Inc.

Complete source-backed cash-flow history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$230.38M
2026-03-31-$632.78M$4.38M-$75.36M$1.78M-$31.65M$223.93M
2025-12-31-$61.94M$3.87M-$70.38M$903,000.00$43.57M$54.89M
2025-09-30-$67.25M
2025-06-30-$92.56M
2025-03-31-$129.65M$3.83M-$85.91M$1.12M$4.13M-$982,000.00
2024-12-31-$59.16M$4.14M-$85.14M$2.11M$9.83M$106.93M
2024-09-30-$85.73M
2024-06-30-$134.56M
2024-03-31-$134.11M$4.56M-$106.98M$1.26M-$35.62M$10.23M
2023-12-31-$233.39M$4.56M-$115.27M$7.96M$2.25M$200.54M
2023-09-30-$95.58M
2023-06-30-$137.88M
2023-03-31-$116.34M$4.68M-$84.31M$8.43M-$8.48M$76.89M
2022-12-31-$108.22M$5.23M-$90.73M$18.93M-$18.89M$109.94M
2022-09-30-$110.94M
2022-06-30-$94.59M
2022-03-31-$102.83M$4.09M-$74.93M$27.35M-$69.31M-$298,000.00
2021-12-31-$91.26M$3.6M-$71.64M$10.4M-$137.8M$325.95M
2021-09-30-$87.63M
2021-06-30-$88.29M
2021-03-31-$79.61M$2.97M-$60.47M$7.08M$31.85M$38.5M
2020-12-31-$67.77M$2.23M-$57.6M-$699,000.00$7.55M$0.00$241,000.00
2020-09-30-$65.6M
2020-06-30-$51.44M
2020-03-31-$37.04M$3.46M-$31.11M$315,000.00$13.99M-$123,000.00
2019-12-31-$107.63M$7.24M-$105.63M$785,000.00$9.26M$2M$75.63M
2019-09-30-$15.58M
2019-06-30-$16.68M
2019-03-31-$17.89M$2.4M-$13.08M$2.1M-$19.46M$39.2M
2018-12-31-$17.34M$2.79M-$14.03M$2.05M$15.91M$228,000.00-$370,000.00
2018-09-30-$23.64M
2018-06-30-$27.73M
2018-03-31-$27.52M$1.62M-$15.51M$4.9M$2.92M$0.00-$85,000.00
2017-12-31-$24.49M$1.57M-$13.64M$11.43M$19.73M$2.77M-$3.14M
2017-09-30-$23.97M
2017-06-30-$23.45M
2017-03-31-$24.52M$1.16M-$10.06M$4.51M$1.05M
2016-12-31-$24.24M$1.84M-$10.75M$1.36M$3.95M
2016-09-30-$31.9M
2016-06-30-$34M
2016-03-31-$30.68M$485,000.00-$8.86M$1.07M$2.55M
2015-12-31-$26.82M$491,000.00-$10.94M$955,000.00$0.00
2015-09-30-$46.31M
2015-06-30-$130.89M
2015-03-31-$32.85M$26,000.00-$7.37M$38,000.00
2014-12-31-$2.76M-$43,000.00-$2.57M$37,000.00
2014-09-30-$896,000.00
2014-06-30-$1.4M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$351.4M$15.53M-$304.94M$3.85M-$149.8M$400.24M
2024-12-31-$413.56M$17.55M-$391.24M$6.89M-$12.25M$281.63M
2023-12-31-$583.2M$18.51M-$366.76M$30.58M-$30.47M$558.34M
2022-12-31-$416.57M$18.26M-$337.51M$78.16M$27.3M$233.61M
2021-12-31-$346.79M$14.24M-$274.42M$33.56M-$84.89M$0.00$505.44M
2020-12-31-$221.85M$12.74M-$171.72M$1.67M-$19.81M$0.00$150.68M
2019-12-31-$157.78M$14.04M-$152.11M$4.29M$18.55M$2.5M$114.28M
2018-12-31-$96.23M$9.56M-$63.38M$13.1M$57.1M$228,000.00-$771,000.00
2017-12-31-$96.42M$5.57M-$48.78M$34.82M$99.55M$15.23M-$34.98M
2016-12-31-$120.81M$3.61M-$38.59M$6.56M-$113.67M$15.85M-$15.56M
2015-12-31-$236.88M$1.47M-$25.31M$2.24M$4.8M
2014-12-31-$6.19M$36,000.00-$5.42M$235,000.00$0.00
2013-12-31-$2.05M$4,000.00-$668,000.00$3,000.00